Literature DB >> 25940910

Hypoxanthine deregulates genes involved in early neuronal development. Implications in Lesch-Nyhan disease pathogenesis.

R J Torres1,2, J G Puig3.   

Abstract

Neurological manifestations in Lesch-Nyhan disease (LND) are attributed to the effect of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency on the nervous system development. HPRT deficiency causes the excretion of increased amounts of hypoxanthine into the extracellular medium and we hypothesized that HPRT deficiency related to hypoxanthine excess may then lead, directly or indirectly, to transcriptional aberrations in a variety of genes essential for the function and development of striatal progenitor cells. We have examined the effect of hypoxanthine excess on the differentiation of neurons in the well-established human NTERA-2 cl.D1 (NT2/D1) embryonic carcinoma neurogenesis model. NT2/D1 cells differentiate along neuroectodermal lineages after exposure to retinoic acid (RA). Hypoxanthine effects on RA-differentiation were examined by the changes on the expression of various transcription factor genes essential to neuronal differentiation and by the changes in tyrosine hydroxylase (TH), dopamine, adenosine and serotonin receptors (DRD, ADORA, HTR). We report that hypoxanthine excess deregulate WNT4, from Wnt/β-catenin pathway, and engrailed homeobox 1 gene and increased TH and dopamine DRD1, adenosine ADORA2A and serotonin HTR7 receptors, whose over expression characterize early neuro-developmental processes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25940910     DOI: 10.1007/s10545-015-9854-4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  27 in total

1.  Abnormal purine and pyrimidine nucleotide content in primary astroglia cultures from hypoxanthine-guanine phosphoribosyltransferase-deficient transgenic mice.

Authors:  D Pelled; O Sperling; E Zoref-Shani
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

2.  Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: a cross-sectional study.

Authors:  David J Schretlen; Mark Varvaris; Tiffany E Ho; Tracy D Vannorsdall; Barry Gordon; James C Harris; H A Jinnah
Journal:  Lancet Neurol       Date:  2013-12       Impact factor: 44.182

3.  Hypoxanthine impairs morphogenesis and enhances proliferation of a neuroblastoma model of Lesch Nyhan syndrome.

Authors:  M H Ma; N C Stacey; G P Connolly
Journal:  J Neurosci Res       Date:  2001-03-15       Impact factor: 4.164

4.  Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase.

Authors:  F M Rosenbloom; J F Henderson; I C Caldwell; W N Kelley; J E Seegmiller
Journal:  J Biol Chem       Date:  1968-03-25       Impact factor: 5.157

5.  Hypoxanthine-guanine phosphoribosyltransferase-deficiency produces aberrant neurite outgrowth of rodent neuroblastoma used to model the neurological disorder Lesch Nyhan syndrome.

Authors:  G P Connolly
Journal:  Neurosci Lett       Date:  2001-11-13       Impact factor: 3.046

6.  Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways.

Authors:  Rong Fu; Diane Sutcliffe; Hong Zhao; Xinyi Huang; David J Schretlen; Steve Benkovic; H A Jinnah
Journal:  Mol Genet Metab       Date:  2014-11-08       Impact factor: 4.797

7.  Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients.

Authors:  M G García; J G Puig; R J Torres
Journal:  Brain Behav Immun       Date:  2009-07-25       Impact factor: 7.217

Review 8.  Delineation of the motor disorder of Lesch-Nyhan disease.

Authors:  H A Jinnah; Jasper E Visser; James C Harris; Alfonso Verdu; Laura Larovere; Irene Ceballos-Picot; Pedro Gonzalez-Alegre; Vladimir Neychev; Rosa J Torres; Olivier Dulac; Isabelle Desguerre; David J Schretlen; Kenneth L Robey; Gabor Barabas; Bastiaan R Bloem; William Nyhan; Raquel De Kremer; Gary E Eddey; Juan G Puig; Stephen G Reich
Journal:  Brain       Date:  2006-03-20       Impact factor: 13.501

9.  Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: implications for Lesch-Nyhan disease pathogenesis.

Authors:  Irene Ceballos-Picot; Lionel Mockel; Marie-Claude Potier; Luce Dauphinot; Thomas L Shirley; Raoul Torero-Ibad; Julia Fuchs; H A Jinnah
Journal:  Hum Mol Genet       Date:  2009-04-02       Impact factor: 6.150

10.  Striatal neurodevelopment is dysregulated in purine metabolism deficiency and impacts DARPP-32, BDNF/TrkB expression and signaling: new insights on the molecular and cellular basis of Lesch-Nyhan Syndrome.

Authors:  Ghiabe-Henri Guibinga; Nikki Barron; William Pandori
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more
  7 in total

1.  Hypoxanthine Intrastriatal Administration Alters Neuroinflammatory Profile and Redox Status in Striatum of Infant and Young Adult Rats.

Authors:  Helena Biasibetti; Paula Pierozan; André Felipe Rodrigues; Vanusa Manfredini; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2016-03-24       Impact factor: 5.590

2.  HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch-Nyhan disease.

Authors:  J E Visser; S M Kolk; J S Witteveen; S R Loopstok; L Luque Ballesteros; A Boonstra; N H M van Bakel; W H P van Boekel; G J M Martens
Journal:  Cell Mol Life Sci       Date:  2022-06-04       Impact factor: 9.207

3.  A Trivalent Enzymatic System for Uricolytic Therapy of HPRT Deficiency and Lesch-Nyhan Disease.

Authors:  Luca Ronda; Marialaura Marchetti; Riccardo Piano; Anastasia Liuzzi; Romina Corsini; Riccardo Percudani; Stefano Bettati
Journal:  Pharm Res       Date:  2017-05-15       Impact factor: 4.200

Review 4.  Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases.

Authors:  Marta Fumagalli; Davide Lecca; Maria P Abbracchio; Stefania Ceruti
Journal:  Front Pharmacol       Date:  2017-12-19       Impact factor: 5.810

5.  Hippocampal Metabolite Profiles in Two Rat Models of Autism: NMR-Based Metabolomics Studies.

Authors:  B Toczylowska; E Zieminska; P Senator; J W Lazarewicz
Journal:  Mol Neurobiol       Date:  2020-05-28       Impact factor: 5.590

Review 6.  Emerging Role of Purine Metabolizing Enzymes in Brain Function and Tumors.

Authors:  Mercedes Garcia-Gil; Marcella Camici; Simone Allegrini; Rossana Pesi; Edoardo Petrotto; Maria Grazia Tozzi
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

7.  Zinc and Copper Brain Levels and Expression of Neurotransmitter Receptors in Two Rat ASD Models.

Authors:  Elzbieta Zieminska; Anna Ruszczynska; Justyna Augustyniak; Beata Toczylowska; Jerzy W Lazarewicz
Journal:  Front Mol Neurosci       Date:  2021-06-29       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.